Suez Canal Bank (S.A.E) (EGX:CANA)

Market Cap	15.29B
Revenue (ttm)	10.18B
Net Income (ttm)	5.62B
Shares Out	650.00M
EPS (ttm)	8.64
PE Ratio	2.72
Forward PE	2.45
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,722
Average Volume	59,761
Open	23.79
Previous Close	23.79
Day's Range	23.45 - 23.98
52-Week Range	10.02 - 27.00
Beta	0.41
RSI	45.45
Earnings Date	Aug 12, 2025

About Revance Therapeutics

Suez Canal Bank (S.A.E) provides retail, corporate, and investment banking services in the Arab Republic of Egypt. The company provides personal banking products and services, including savings and current accounts; time deposits and certificates of deposit; payroll services; debit, credit, Meeza, and prepaid cards; personal, cash-secured, bankers, pensions, semi-covered, doctors, auto, property ownership, club membership, and education loans, as well as loan against payroll, full salary/installment transfer, self-employed and professionals, an...

• Industry: Commercial Banks
• Founded: 1978
• Employees: 1,673
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: CANA

Financial Performance

In 2024, Suez Canal Bank (S.A.E)'s revenue was 9.23 billion, an increase of 79.82% compared to the previous year's 5.13 billion. Earnings were 5.00 billion, an increase of 147.73%.